Crossmark

Prediction of non-muscle-invasive bladder cancer recurrence during intravesical BCG immunotherapy by use of peripheral blood eosinophil count and percentage: a preliminary report

Crossref DOI link: https://doi.org/10.1007/s00262-020-02673-x

Published Online: 2020-07-22

Published Print: 2021-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Temiz, Mustafa Zafer https://orcid.org/0000-0002-5736-5495
Colakerol, Aykut https://orcid.org/0000-0002-5076-5306
Ulus, Ismail https://orcid.org/0000-0002-2005-9734
Kilic, Enes https://orcid.org/0000-0002-3235-3025
Paslanmaz, Filip https://orcid.org/0000-0003-4556-5518
Sahin, Sergen https://orcid.org/0000-0003-2951-5991
Yuruk, Emrah https://orcid.org/0000-0002-2343-8828
Kandirali, Engin https://orcid.org/0000-0003-0580-2144
Semercioz, Atilla https://orcid.org/0000-0001-8688-4772
Muslumanoglu, Ahmet Yaser https://orcid.org/0000-0002-8691-0886
License Information

Text and Data Mining valid from 2020-07-22

Version of Record valid from 2020-07-22
More Information

Article History

Received: 21 May 2020

Accepted: 15 July 2020

First Online: 22 July 2020

Compliance with ethical standards

:

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below